JP2018000206A - 核酸試料の調製方法 - Google Patents

核酸試料の調製方法 Download PDF

Info

Publication number
JP2018000206A
JP2018000206A JP2017200863A JP2017200863A JP2018000206A JP 2018000206 A JP2018000206 A JP 2018000206A JP 2017200863 A JP2017200863 A JP 2017200863A JP 2017200863 A JP2017200863 A JP 2017200863A JP 2018000206 A JP2018000206 A JP 2018000206A
Authority
JP
Japan
Prior art keywords
nucleic acid
skin
subject
rna
ssl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017200863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018000206A5 (cg-RX-API-DMAC7.html
Inventor
高良 井上
Takayoshi Inoue
高良 井上
八谷　輝
Akira Hachiya
輝 八谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of JP2018000206A publication Critical patent/JP2018000206A/ja
Publication of JP2018000206A5 publication Critical patent/JP2018000206A5/ja
Priority to JP2022065024A priority Critical patent/JP7323671B2/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/18—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by features of a layer of foamed material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2017200863A 2016-07-08 2017-10-17 核酸試料の調製方法 Pending JP2018000206A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022065024A JP7323671B2 (ja) 2016-07-08 2022-04-11 核酸試料の調製方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPPCT/JP2016/070343 2016-07-08
JP2016070343 2016-07-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017545765A Division JP6231252B1 (ja) 2016-07-08 2017-06-07 核酸試料の調製方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022065024A Division JP7323671B2 (ja) 2016-07-08 2022-04-11 核酸試料の調製方法

Publications (2)

Publication Number Publication Date
JP2018000206A true JP2018000206A (ja) 2018-01-11
JP2018000206A5 JP2018000206A5 (cg-RX-API-DMAC7.html) 2020-10-22

Family

ID=60912100

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017200863A Pending JP2018000206A (ja) 2016-07-08 2017-10-17 核酸試料の調製方法
JP2022065024A Active JP7323671B2 (ja) 2016-07-08 2022-04-11 核酸試料の調製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022065024A Active JP7323671B2 (ja) 2016-07-08 2022-04-11 核酸試料の調製方法

Country Status (6)

Country Link
US (1) US11913061B2 (cg-RX-API-DMAC7.html)
EP (2) EP3372693B1 (cg-RX-API-DMAC7.html)
JP (2) JP2018000206A (cg-RX-API-DMAC7.html)
KR (1) KR101961076B1 (cg-RX-API-DMAC7.html)
CN (1) CN108699589B (cg-RX-API-DMAC7.html)
WO (1) WO2018008319A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021215532A1 (ja) * 2020-04-24 2021-10-28 花王株式会社 月経前症候群の重症度検出方法
WO2021221138A1 (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020091044A1 (ja) 2018-11-01 2020-05-07 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法
US20240294902A1 (en) * 2020-01-10 2024-09-05 Kao Corporation Method for amplifying nucleic acid
CN115279901A (zh) * 2020-03-11 2022-11-01 花王株式会社 来自皮肤表面脂质的rna的制备方法
JP2021175958A (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎検出用タンパク質マーカーの調製方法
JP2021175382A (ja) * 2020-05-01 2021-11-04 花王株式会社 乳幼児アトピー性皮膚炎の検出方法
JP2021175381A (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
EP4151728A4 (en) 2020-05-14 2024-06-05 Kao Corporation METHOD FOR PROCESSING RNA INFORMATION DATA
JP2021180654A (ja) * 2020-05-14 2021-11-25 花王株式会社 パーキンソン病の検出方法
EP4180536A4 (en) 2020-07-10 2024-08-07 Kao Corporation Method for detecting severity of atopic dermatitis
KR102770548B1 (ko) 2020-08-28 2025-02-19 카오카부시키가이샤 검체 보존구
CN116057177A (zh) 2020-08-28 2023-05-02 花王株式会社 Rna的保存方法
CN116194595A (zh) * 2020-09-16 2023-05-30 花王株式会社 婴幼儿特应性皮炎的检测方法
CN116635526A (zh) 2020-11-30 2023-08-22 花王株式会社 特应性皮炎的重症度的检测方法
JP7655720B2 (ja) * 2020-12-18 2025-04-02 花王株式会社 ストレスマーカー及びそれを用いた慢性ストレスレベルの検出方法
JP7655721B2 (ja) * 2020-12-18 2025-04-02 花王株式会社 疲労マーカー及びそれを用いた疲労の検出方法
US20240117433A1 (en) * 2021-02-12 2024-04-11 Kao Corporation Preparation method for nucleic acid sample derived from skin stratum corneum
WO2022255378A1 (ja) 2021-05-31 2022-12-08 花王株式会社 皮膚表上脂質検体内部標準遺伝子
JP7750481B2 (ja) * 2021-06-22 2025-10-07 花王株式会社 内臓脂肪面積の検出方法
JP2023002298A (ja) * 2021-06-22 2023-01-10 花王株式会社 糖尿病指標値の検出方法
JP2023038883A (ja) * 2021-09-07 2023-03-17 花王株式会社 ＳＡＲＳ－ＣｏＶ－２の検出方法
JP2023075831A (ja) * 2021-11-19 2023-05-31 花王株式会社 炭酸ガス製剤の有効性を検出する方法
NL2030378B1 (en) 2021-12-31 2023-07-05 Lumicks Ca Holding B V Selecting forces for means and methods involving cellular avidity
EP4624591A1 (en) 2022-11-24 2025-10-01 Kao Corporation Internal standard gene in skin surface lipid specimen
WO2025084419A1 (ja) * 2023-10-20 2025-04-24 花王株式会社 肌タイプの分類方法

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003533965A (ja) * 1998-08-14 2003-11-18 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 皮膚の異常症状を治療するためのヒト・ステアロイル−ＣｏＡデサチュラーゼ−関連組成物および方法
JP2005192409A (ja) * 2003-12-26 2005-07-21 Shiseido Co Ltd 体毛からｒｎａを抽出するための方法
JP2010115178A (ja) * 2008-11-14 2010-05-27 Nippon Menaade Keshohin Kk 皮膚の炎症の予測方法及びその用途
US20100285463A1 (en) * 2007-06-29 2010-11-11 Medizinische Univversitat Innsbruck Selecting nucleic acid samples suitable for genotyping
WO2014082083A1 (en) * 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods
US20140274789A1 (en) * 2011-08-11 2014-09-18 Andreas Keller Complex sets of mirnas as non-invasive biomarkers for psoriasis
JP2015512255A (ja) * 2012-03-17 2015-04-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ざ瘡の高速診断および個人化された治療
JP2015518705A (ja) * 2012-04-02 2015-07-06 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド
JP2015528699A (ja) * 2012-07-13 2015-10-01 ラボラトワール エクスパンシアンス 小児皮膚の分子マーカーの同定方法
JP2016509471A (ja) * 2012-12-14 2016-03-31 マインデラ コーポレイション バイオマーカーの検出および収集のための方法およびデバイス
WO2016172598A1 (en) * 2015-04-22 2016-10-27 The Broad Institute Inc. Exosomes and uses thereof
WO2016191644A1 (en) * 2015-05-28 2016-12-01 Lucigen Corporation Molecular detection of rna

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5774699A (en) * 1998-08-14 2000-03-06 Johnson & Johnson Consumer Companies, Inc. Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
US6645611B2 (en) * 2001-02-09 2003-11-11 3M Innovative Properties Company Dispensable oil absorbing skin wipes
US6638611B2 (en) * 2001-02-09 2003-10-28 3M Innovative Properties Company Multipurpose cosmetic wipes
US6649181B1 (en) * 2002-05-29 2003-11-18 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic adhesive strip
EP1734814B1 (en) 2004-03-17 2015-01-21 Revivicor, Inc. Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
US7183057B2 (en) 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
KR101267430B1 (ko) 2006-10-04 2013-05-30 문우철 핵산을 안정적으로 보관하는 새로운 피부 유전자 카드와이를 이용한 유전자 분석방법, 그리고 이의 응용 방법
JP2008222876A (ja) * 2007-03-13 2008-09-25 Institute Of Physical & Chemical Research 生分解性吸油用フィルム
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
JP2011019505A (ja) 2009-01-29 2011-02-03 Mukogawa Gakuin 特定遺伝子を検出する方法
EP3369828B1 (en) * 2011-02-07 2020-07-15 The Governing Council Of The University Of Toronto Bioprobes and methods of use thereof
US20140228233A1 (en) 2011-06-07 2014-08-14 Traci Pawlowski Circulating biomarkers for cancer
EP2834260A4 (en) 2012-04-02 2016-08-10 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PREPARATION OF MEMBRANE PROTEINS
EP2857521A4 (en) 2012-05-31 2015-12-30 Takeda Pharmaceutical METHOD FOR ASSESSING ENDOMETRIOSIS
JP5895244B2 (ja) 2014-06-27 2016-03-30 株式会社ライラック研究所 機能性化粧水
JP6650240B2 (ja) 2014-11-25 2020-02-19 花王株式会社 メラニン制御剤の探索方法

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003533965A (ja) * 1998-08-14 2003-11-18 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 皮膚の異常症状を治療するためのヒト・ステアロイル−ＣｏＡデサチュラーゼ−関連組成物および方法
JP2005192409A (ja) * 2003-12-26 2005-07-21 Shiseido Co Ltd 体毛からｒｎａを抽出するための方法
US20100285463A1 (en) * 2007-06-29 2010-11-11 Medizinische Univversitat Innsbruck Selecting nucleic acid samples suitable for genotyping
JP2010115178A (ja) * 2008-11-14 2010-05-27 Nippon Menaade Keshohin Kk 皮膚の炎症の予測方法及びその用途
US20140274789A1 (en) * 2011-08-11 2014-09-18 Andreas Keller Complex sets of mirnas as non-invasive biomarkers for psoriasis
JP2015512255A (ja) * 2012-03-17 2015-04-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ざ瘡の高速診断および個人化された治療
JP2015518705A (ja) * 2012-04-02 2015-07-06 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド
JP2015528699A (ja) * 2012-07-13 2015-10-01 ラボラトワール エクスパンシアンス 小児皮膚の分子マーカーの同定方法
WO2014082083A1 (en) * 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods
JP2016509471A (ja) * 2012-12-14 2016-03-31 マインデラ コーポレイション バイオマーカーの検出および収集のための方法およびデバイス
WO2016172598A1 (en) * 2015-04-22 2016-10-27 The Broad Institute Inc. Exosomes and uses thereof
WO2016191644A1 (en) * 2015-05-28 2016-12-01 Lucigen Corporation Molecular detection of rna

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
"Detection of Propionibacterium acnes 16S rRNA and Lipase Genes from Sebum Samples Collected on Lipid", PRESSURE BIOSCIENCES INC. PRESS RELEASES, JPN6021016975, 2009, ISSN: 0004678822 *
CRIT. REV. CLIN. LAB. SCI., vol. 51, no. 4, JPN6016037763, 2014, pages 200 - 231, ISSN: 0004501125 *
DIS. AQUAT. ORGAN., vol. 104, no. 3, JPN6016037750, 2013, pages 225 - 236, ISSN: 0004501119 *
FORENSIC. SCI. INT. GENET., vol. 6, no. 5, JPN6016037758, 2012, pages 565 - 577, ISSN: 0004501123 *
GENOMICS INSIGHTS, vol. 1, JPN6016037755, 2008, pages 17 - 24, ISSN: 0004501122 *
INT. J. SYST. EVOL. MICROBIOL., vol. Vol.59, Pt.9, JPN6016037767, 2009, pages 2346 - 2351, ISSN: 0004501127 *
J. INVEST. DERMATOL., vol. 126, no. 10, JPN6016037759, 2006, pages 2234 - 2241, ISSN: 0004501124 *
LETT. APPL. MICROBIOL., vol. 56, no. 1, JPN6016037751, 2013, pages 79 - 82, ISSN: 0004501120 *
Z. NATURFORSCH. C, vol. Vol.68, No.3-4, JPN6016037753, 2013, pages 164 - 168, ISSN: 0004501121 *
日本分子生物学会年会プログラム・要旨集, vol. 37, JPN6016037764, 2014, pages 2 - 0017, ISSN: 0004501126 *
日本生化学大会, vol. 88, JPN6016037769, 2015, pages 4 - 21, ISSN: 0004501128 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021215532A1 (ja) * 2020-04-24 2021-10-28 花王株式会社 月経前症候群の重症度検出方法
JP2021175395A (ja) * 2020-04-24 2021-11-04 花王株式会社 月経前症候群の重症度検出方法
CN115443337A (zh) * 2020-04-24 2022-12-06 花王株式会社 经前综合征的重症度检测方法
WO2021221138A1 (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法

Also Published As

Publication number Publication date
US20180371524A1 (en) 2018-12-27
EP3372693B1 (en) 2020-02-12
EP3719138B1 (en) 2022-09-21
KR101961076B1 (ko) 2019-03-21
JP7323671B2 (ja) 2023-08-08
EP3719138A1 (en) 2020-10-07
WO2018008319A1 (ja) 2018-01-11
EP3372693A4 (en) 2018-10-10
CN108699589A (zh) 2018-10-23
EP3372693A1 (en) 2018-09-12
KR20180081624A (ko) 2018-07-16
US11913061B2 (en) 2024-02-27
CN108699589B (zh) 2021-08-13
JP2022097507A (ja) 2022-06-30

Similar Documents

Publication Publication Date Title
JP7323671B2 (ja) 核酸試料の調製方法
JP7626515B2 (ja) 被験体の皮膚細胞に由来する核酸の調製方法
JP2018000206A5 (cg-RX-API-DMAC7.html)
US20240294966A1 (en) Method for preparing nucleic acid sample
JP5311439B2 (ja) 皮膚の状態を評価する方法及びその用途
JP6943960B2 (ja) 乾燥の徴候を呈している皮膚を診断するための方法
KR20200041971A (ko) 노화 징후를 나타내는 피부의 진단 방법
JP5653783B2 (ja) 皮膚表皮内水分保持能評価法
JP5535571B2 (ja) 表皮ターンオーバーの評価方法及びその用途
JP7655720B2 (ja) ストレスマーカー及びそれを用いた慢性ストレスレベルの検出方法
KR101932248B1 (ko) 지방산 연장 효소 발현 및 탄소사슬 발현 조절을 통한 아토피성 피부의 피부 장벽 기능 회복 효능 물질 스크리닝 방법
JP7655721B2 (ja) 疲労マーカー及びそれを用いた疲労の検出方法
JP7712792B2 (ja) Ｒｎａ情報のデータ処理方法
JP5653673B2 (ja) 皮膚血管機能評価法
JP2021117164A (ja) 皮膚炎症状態の評価方法
Hadeler et al. Innovations in translational research in dermatology: minimally invasive methods for biosample acquisition
JP2025184029A (ja) 肌状態の推定方法、推定装置、推定プログラム、肌状態改善剤及び／又は美容手段の選択方法、肌状態を推定するためのマーカーを選択する方法
WO2021215531A1 (ja) 月経周期マーカー
JP2022097302A (ja) 睡眠状態マーカー及びそれを用いた睡眠状態の検出方法
JP2023075830A (ja) 皮膚外用製剤の有効性の評価方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210511

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210706

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210831

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220111